Modified Quadruplet Regimen Effective in Older Myeloma Patients

(MedPage Today) — A modified version of the regimen combining the anti-CD38 monoclonal antibody isatuximab (Sarclisa) with bortezomib (Velcade), lenalidomide (Revlimid), and limited dexamethasone was safe and effective for older multiple myeloma…

Source link : https://www.medpagetoday.com/hematologyoncology/myeloma/114075

Author :

Publish date : 2025-02-04 20:34:38

Copyright for syndicated content belongs to the linked Source.